Duke University Health System, Division of Cell Therapy, Heme Malignancies Program is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Duke University Health System, Division of Cell Therapy, Heme Malignancies Program has participated in 1 clinical trials.
Therapeutic areas: Hemoglobinuria, Paroxysmal.
Sponsors: Alexion Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Health System, Division of Cell Therapy, Heme Malignancies Program has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Health System, Division of Cell Therapy, Heme Malignancies Program has 1 clinical trials on record. Their work covers Hemoglobinuria, Paroxysmal.
Duke University Health System, Division of Cell Therapy, Heme Malignancies Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.